CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

You are here

  • Article number: RC0300
    Add to compare

    SOX11 Polyclonal

    Description Mantle cell lymphoma (MCL) accounts for 5% to 10% of mature B-cell neoplasms and is an aggressive disease genetically characterized by overexpression of cyclin D1 (CCND1), an important regulator of the G1/S phase of the cell cycle, due to the specific translocation t(11;14)(q13;q32). Cyclin D1 overexpression is the hallmark of MCL. However, approximately 5%-10% of MCLs lack cyclin D1 expression and may be misdiagnosed by overreliance on cyclin D1 IHC. Recently, SOX-11 protein expression in MCL has been investigated by immunohistochemistry. Two studies have evaluated SOX-11 expression in MCL and found strong nuclear expression of SOX-11 in almost all cyclin D1-positive MCL (93%-100%). In all 13 cases of cyclin D1-negative MCL, SOX-11 was strongly expressed. The authors also found that blastoid variant of MCL can be differentiated from CD5+ diffuse large B cell lymphoma, which was negative for SOX-11. In summary, nuclear protein expression of SOX-11 is highly associated with both cyclin
    Host Rabbit
    Application Peptide ELISA, Immunohistochemistry (IHC), Western Blot (WB)
    Reactivity Human, Mouse,Rat, Bovine,Pig (Porcine)
    Unit 1 ml
    more info
    Normal leadtime 14 days
    Calculated total €374,40 
    Add to cart
  • Article number: RC0300RTU7
    Add to compare

    SOX11 Polyclonal

    Description Mantle cell lymphoma (MCL) accounts for 5% to 10% of mature B-cell neoplasms and is an aggressive disease genetically characterized by overexpression of cyclin D1 (CCND1), an important regulator of the G1/S phase of the cell cycle, due to the specific translocation t(11;14)(q13;q32). Cyclin D1 overexpression is the hallmark of MCL. However, approximately 5%-10% of MCLs lack cyclin D1 expression and may be misdiagnosed by overreliance on cyclin D1 IHC. Recently, SOX-11 protein expression in MCL has been investigated by immunohistochemistry. Two studies have evaluated SOX-11 expression in MCL and found strong nuclear expression of SOX-11 in almost all cyclin D1-positive MCL (93%-100%). In all 13 cases of cyclin D1-negative MCL, SOX-11 was strongly expressed. The authors also found that blastoid variant of MCL can be differentiated from CD5+ diffuse large B cell lymphoma, which was negative for SOX-11. In summary, nuclear protein expression of SOX-11 is highly associated with both cyclin
    Host Rabbit
    Application Peptide ELISA, Immunohistochemistry (IHC), Western Blot (WB)
    Reactivity Human, Mouse,Rat, Bovine,Pig (Porcine)
    Unit 7 ml
    more info
    Normal leadtime 14 days
    Calculated total €187,20 
    Add to cart
Please wait